iiinova — where your digital self keeps evolving

Julius Enssle

@jenssle.bsky.social

Physician Scientist | NCI/NIH Bethesda and Frankfurt Cancer Institute | focus on computational hematology, lymphoid malignancies, translational multiomics | views are my own

Posts Replies Media

Reposted by Julius Enssle

ProLOEWE @proloewe.bsky.social · 06/07/2026

AI meets #CancerResearch: Researchers from LOEWE CARISMa & @loewe-fci.bsky.social identified biological markers of high-risk diffuse large B-cell lymphoma using interpretable🤖AI. A key step toward earlier risk detection+more🎯personalized cancer treatment. @goetheuni.bsky.social @jenssle.bsky.social

052

Julius Enssle @jenssle.bsky.social · 04/06/2026

🎉🚀 We're excited to share our latest insights on #DLBCL www.cell.com/cancer-cell/...! 🧵 How can we understand its clinical & molecular heterogeneity by incorporating the proteome?

cell.com

Pathogenesis of diffuse large B cell lymphoma proteogenotypes

Enssle et al. perform transcriptomic and proteomic profiling of diffuse large B cell lymphoma (DLBCL), revealing seven proteogenotypes (PGs) that reflect molecular and tumor microenvironment features ...

131

Julius Enssle @jenssle.bsky.social · 17/01/2026

First post here, but very happy to share our most recent findings from studying DLBCL at single-cell granularity (www.cell.com/cancer-cell/.... This was a great collaborative effort, and I am honored to have contributed as co-first author. Here's a short recap of the highlights. 🧵👇

220